0.025530
0.000000
0.000000
0.000000
0.025530
0.000000
0.000000
0.000000
0.008091
0.00000
0.00000
0.00000
Brzozowski, A.M.
Jiracek, J.
Zakova, L.
Antolikova, E.
Watson, C.J.
Turkenburg, J.P.
Dodson, G.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
39.170
39.170
123.593
C2 H3 O2 -1
59.044
ACETATE ION
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C7 H12 N4 O
168.196
n
N-ALPHA-METHYL-L-HISTIDINAMIDE
N-METHYL-L-HISTIDINAMIDE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
N
1
N
C
N
2
N
O
N
3
N
O
N
4
N
C
N
5
N
H
N
6
N
H
N
7
N
H
N
8
N
N
N
9
S
C
N
10
N
C
N
11
N
O
N
12
N
C
N
13
N
O
N
14
N
H
N
15
N
H
N
16
N
H
N
17
N
H
N
18
N
H
N
19
N
H
N
20
N
H
N
21
N
N
N
22
S
C
N
23
N
C
N
24
N
O
N
25
N
C
N
26
N
C
N
27
N
C
N
28
N
N
N
29
N
C
N
30
N
N
N
31
N
N
N
32
N
O
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
H
N
42
N
H
N
43
N
H
N
44
N
H
N
45
N
H
N
46
N
H
N
47
N
H
N
48
N
N
N
49
S
C
N
50
N
C
N
51
N
O
N
52
N
C
N
53
N
C
N
54
N
O
N
55
N
N
N
56
N
O
N
57
N
H
N
58
N
H
N
59
N
H
N
60
N
H
N
61
N
H
N
62
N
H
N
63
N
H
N
64
N
H
N
65
N
N
N
66
R
C
N
67
N
C
N
68
N
O
N
69
N
C
N
70
N
S
N
71
N
O
N
72
N
H
N
73
N
H
N
74
N
H
N
75
N
H
N
76
N
H
N
77
N
H
N
78
N
H
N
79
N
N
N
80
S
C
N
81
N
C
N
82
N
O
N
83
N
C
N
84
N
C
N
85
N
C
N
86
N
O
N
87
N
N
N
88
N
O
N
89
N
H
N
90
N
H
N
91
N
H
N
92
N
H
N
93
N
H
N
94
N
H
N
95
N
H
N
96
N
H
N
97
N
H
N
98
N
H
N
99
N
N
N
100
S
C
N
101
N
C
N
102
N
O
N
103
N
C
N
104
N
C
N
105
N
C
N
106
N
O
N
107
N
O
N
108
N
O
N
109
N
H
N
110
N
H
N
111
N
H
N
112
N
H
N
113
N
H
N
114
N
H
N
115
N
H
N
116
N
H
N
117
N
H
N
118
N
N
N
119
N
C
N
120
N
C
N
121
N
O
N
122
N
O
N
123
N
H
N
124
N
H
N
125
N
H
N
126
N
H
N
127
N
H
N
128
N
N
N
129
S
C
N
130
N
C
N
131
N
O
N
132
N
C
Y
133
N
C
Y
134
N
N
Y
135
N
C
Y
136
N
C
Y
137
N
N
N
138
N
O
N
139
N
H
N
140
N
H
N
141
N
H
N
142
N
H
N
143
N
H
N
144
N
H
N
145
N
H
N
146
N
H
N
147
N
H
N
148
N
H
N
149
N
O
N
150
N
H
N
151
N
H
N
152
N
N
N
153
S
C
N
154
N
C
Y
155
N
C
Y
156
N
N
Y
157
N
C
Y
158
N
C
Y
159
N
N
N
160
N
C
N
161
N
O
N
162
N
N
N
163
N
C
N
164
N
H
N
165
N
H
N
166
N
H
N
167
N
H
N
168
N
H
N
169
N
H
N
170
N
H
N
171
N
H
N
172
N
H
N
173
N
H
N
174
N
H
N
175
N
H
N
176
N
N
N
177
S
C
N
178
N
C
N
179
N
O
N
180
S
C
N
181
N
C
N
182
N
C
N
183
N
C
N
184
N
O
N
185
N
H
N
186
N
H
N
187
N
H
N
188
N
H
N
189
N
H
N
190
N
H
N
191
N
H
N
192
N
H
N
193
N
H
N
194
N
H
N
195
N
H
N
196
N
H
N
197
N
H
N
198
N
N
N
199
S
C
N
200
N
C
N
201
N
O
N
202
N
C
N
203
N
C
N
204
N
C
N
205
N
C
N
206
N
O
N
207
N
H
N
208
N
H
N
209
N
H
N
210
N
H
N
211
N
H
N
212
N
H
N
213
N
H
N
214
N
H
N
215
N
H
N
216
N
H
N
217
N
H
N
218
N
H
N
219
N
H
N
220
N
N
N
221
S
C
N
222
N
C
N
223
N
O
N
224
N
C
Y
225
N
C
Y
226
N
C
Y
227
N
C
Y
228
N
C
Y
229
N
C
Y
230
N
C
N
231
N
O
N
232
N
H
N
233
N
H
N
234
N
H
N
235
N
H
N
236
N
H
N
237
N
H
N
238
N
H
N
239
N
H
N
240
N
H
N
241
N
H
N
242
N
H
N
243
N
N
N
244
S
C
N
245
N
C
N
246
N
O
N
247
N
C
N
248
N
O
N
249
N
O
N
250
N
H
N
251
N
H
N
252
N
H
N
253
N
H
N
254
N
H
N
255
N
H
N
256
N
H
N
257
N
N
N
258
S
C
N
259
N
C
N
260
N
O
N
261
R
C
N
262
N
O
N
263
N
C
N
264
N
O
N
265
N
H
N
266
N
H
N
267
N
H
N
268
N
H
N
269
N
H
N
270
N
H
N
271
N
H
N
272
N
H
N
273
N
H
N
274
N
N
N
275
S
C
N
276
N
C
N
277
N
O
N
278
N
C
Y
279
N
C
Y
280
N
C
Y
281
N
C
Y
282
N
C
Y
283
N
C
Y
284
N
C
N
285
N
O
N
286
N
O
N
287
N
H
N
288
N
H
N
289
N
H
N
290
N
H
N
291
N
H
N
292
N
H
N
293
N
H
N
294
N
H
N
295
N
H
N
296
N
H
N
297
N
H
N
298
N
N
N
299
S
C
N
300
N
C
N
301
N
O
N
302
N
C
N
303
N
C
N
304
N
C
N
305
N
O
N
306
N
H
N
307
N
H
N
308
N
H
N
309
N
H
N
310
N
H
N
311
N
H
N
312
N
H
N
313
N
H
N
314
N
H
N
315
N
H
N
316
N
H
N
1
N
doub
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
sing
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
doub
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
doub
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
sing
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
doub
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
sing
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
sing
N
51
N
doub
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
doub
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
sing
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
doub
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
sing
N
75
N
sing
N
76
N
sing
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
doub
N
81
N
sing
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
sing
N
88
N
doub
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
sing
N
99
N
doub
N
100
N
sing
N
101
N
sing
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
doub
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
sing
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
doub
N
118
N
sing
N
119
N
sing
N
120
N
sing
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
N
125
N
sing
N
126
N
doub
N
127
N
sing
N
128
N
sing
N
129
N
sing
N
130
N
sing
Y
131
N
sing
Y
132
N
doub
Y
133
N
doub
N
134
N
sing
Y
135
N
sing
N
136
N
sing
Y
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
sing
N
144
N
sing
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
doub
N
149
N
sing
N
150
N
sing
Y
151
N
sing
Y
152
N
doub
Y
153
N
doub
Y
154
N
sing
Y
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
sing
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
doub
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
sing
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
N
193
N
sing
N
194
N
doub
N
195
N
sing
N
196
N
sing
N
197
N
sing
N
198
N
sing
N
199
N
sing
N
200
N
sing
N
201
N
sing
N
202
N
sing
N
203
N
sing
N
204
N
sing
N
205
N
sing
N
206
N
sing
N
207
N
sing
N
208
N
sing
N
209
N
sing
N
210
N
sing
N
211
N
sing
N
212
N
sing
N
213
N
sing
N
214
N
sing
N
215
N
doub
N
216
N
sing
N
217
N
sing
N
218
N
sing
N
219
N
sing
Y
220
N
doub
Y
221
N
sing
Y
222
N
sing
N
223
N
sing
Y
224
N
doub
N
225
N
sing
Y
226
N
doub
N
227
N
sing
Y
228
N
sing
N
229
N
sing
N
230
N
sing
N
231
N
sing
N
232
N
sing
N
233
N
sing
N
234
N
sing
N
235
N
sing
N
236
N
sing
N
237
N
sing
N
238
N
doub
N
239
N
sing
N
240
N
sing
N
241
N
sing
N
242
N
sing
N
243
N
sing
N
244
N
sing
N
245
N
sing
N
246
N
sing
N
247
N
sing
N
248
N
sing
N
249
N
sing
N
250
N
sing
N
251
N
doub
N
252
N
sing
N
253
N
sing
N
254
N
sing
N
255
N
sing
N
256
N
sing
N
257
N
sing
N
258
N
sing
N
259
N
sing
N
260
N
sing
N
261
N
sing
N
262
N
sing
N
263
N
sing
N
264
N
sing
N
265
N
sing
N
266
N
sing
N
267
N
doub
N
268
N
sing
N
269
N
sing
N
270
N
sing
N
271
N
sing
Y
272
N
doub
Y
273
N
sing
Y
274
N
sing
N
275
N
sing
Y
276
N
doub
N
277
N
sing
Y
278
N
doub
N
279
N
sing
Y
280
N
sing
N
281
N
sing
N
282
N
sing
N
283
N
sing
N
284
N
sing
N
285
N
sing
N
286
N
sing
N
287
N
sing
N
288
N
sing
N
289
N
sing
N
290
N
sing
N
291
N
doub
N
292
N
sing
N
293
N
sing
N
294
N
sing
N
295
N
sing
N
296
N
sing
N
297
N
sing
N
298
N
sing
N
299
N
sing
N
300
N
sing
N
301
N
sing
N
302
N
sing
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
107
1966
10.1073/PNAS.0911785107
20133841
Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues.
2010
10.2210/pdb2wrv/pdb
pdb_00002wrv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2009-02-19
ADSC QUANTUM 4r
SINGLE WAVELENGTH
M
x-ray
1
0.933
1.0
ID14-2
ESRF
0.933
SYNCHROTRON
ESRF BEAMLINE ID14-2
2383.698
INSULIN A CHAIN
1
syn
polymer
2992.458
INSULIN B CHAIN
RESIDUES 25-50
YES
1
syn
polymer
59.044
ACETATE ION
1
syn
non-polymer
18.015
water
45
nat
water
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
yes
FVNQHLCGSHLVEALYLVCGERGFF(HS9)
FVNQHLCGSHLVEALYLVCGERGFFH
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2.3
43
NONE
8.2
0.1 NA CITRATE, 0.3 M TRIS PH 8.2, 0.6 MM ZN ACETATE, 0.06% PHENOL
diffrn_detector
refine
reflns
reflns_shell
chem_comp_atom
chem_comp_bond
database_2
pdbx_database_status
pdbx_initial_refinement_model
struct_conn
struct_site
repository
Initial release
Advisory
Version format compliance
Other
Data collection
Refinement description
Data collection
Database references
Derived calculations
Other
Refinement description
1
0
2010-02-09
1
1
2011-07-13
1
2
2012-06-06
1
3
2017-08-30
1
4
2023-12-20
_diffrn_detector.type
_refine.ls_R_factor_R_free
_reflns.d_resolution_low
_reflns_shell.Rmerge_I_obs
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_sf
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES)
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE
INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES
CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN
STRUCTURE OF INSULIN
T6 HUMAN INSULIN AT 1.0 A RESOLUTION
CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16 )
DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2 )
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)];
MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES
INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS
THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER
STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER
ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES
DEHYDRATED T6 HUMAN INSULIN AT 295 K
INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION.
R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES
SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN)
NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES
NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY
STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
DEHYDRATED T6 HUMAN INSULIN AT 100 K
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER
CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE
CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY.
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D;
CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES
DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE
1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
INSULIN, MONOCLINIC CRYSTAL FORM
STRUCTURE OF INSULIN
INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES)
HUMAN INSULIN MUTANT SERB9GLU
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE
STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT.
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES)
AN ACTIVE MINI-PROINSULIN, M2PI
LYS(B28)PRO(B29)-HUMAN INSULIN
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES
INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI-NH2
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2
PDBE
Y
PDBE
2009-09-02
REL
REL
ACT
ACETATE ION
HOH
water
9606
HUMAN
HOMO SAPIENS
sample
9606
HUMAN
HOMO SAPIENS
sample
ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO HS9
B26 TYR MUTATED TO HIS, N ATOM OF B26 PEPTIDE IS
METHYLATED, B27-B30 ARE DELETED, B26 C-TERMINUS IS
FINISHED WITH CONH2 (CARBOXYAMIDE) NOT A COOH GROUP
1MSO
PDB ENTRY 1MSO
PDB
experimental model
ACT
1022
3
ACT
ACT
1022
A
HOH
2001
4
HOH
HOH
2001
A
HOH
2002
4
HOH
HOH
2002
A
HOH
2003
4
HOH
HOH
2003
A
HOH
2004
4
HOH
HOH
2004
A
HOH
2005
4
HOH
HOH
2005
A
HOH
2006
4
HOH
HOH
2006
A
HOH
2007
4
HOH
HOH
2007
A
HOH
2008
4
HOH
HOH
2008
A
HOH
2009
4
HOH
HOH
2009
A
HOH
2010
4
HOH
HOH
2010
A
HOH
2011
4
HOH
HOH
2011
A
HOH
2012
4
HOH
HOH
2012
A
HOH
2013
4
HOH
HOH
2013
A
HOH
2014
4
HOH
HOH
2014
A
HOH
2015
4
HOH
HOH
2015
A
HOH
2016
4
HOH
HOH
2016
A
HOH
2017
4
HOH
HOH
2017
A
HOH
2018
4
HOH
HOH
2018
A
HOH
2019
4
HOH
HOH
2019
A
HOH
2001
4
HOH
HOH
2001
B
HOH
2002
4
HOH
HOH
2002
B
HOH
2003
4
HOH
HOH
2003
B
HOH
2004
4
HOH
HOH
2004
B
HOH
2005
4
HOH
HOH
2005
B
HOH
2006
4
HOH
HOH
2006
B
HOH
2007
4
HOH
HOH
2007
B
HOH
2008
4
HOH
HOH
2008
B
HOH
2009
4
HOH
HOH
2009
B
HOH
2010
4
HOH
HOH
2010
B
HOH
2011
4
HOH
HOH
2011
B
HOH
2012
4
HOH
HOH
2012
B
HOH
2013
4
HOH
HOH
2013
B
HOH
2014
4
HOH
HOH
2014
B
HOH
2015
4
HOH
HOH
2015
B
HOH
2016
4
HOH
HOH
2016
B
HOH
2017
4
HOH
HOH
2017
B
HOH
2018
4
HOH
HOH
2018
B
HOH
2019
4
HOH
HOH
2019
B
HOH
2020
4
HOH
HOH
2020
B
HOH
2021
4
HOH
HOH
2021
B
HOH
2022
4
HOH
HOH
2022
B
HOH
2023
4
HOH
HOH
2023
B
HOH
2024
4
HOH
HOH
2024
B
HOH
2025
4
HOH
HOH
2025
B
HOH
2026
4
HOH
HOH
2026
B
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
n
1
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
HS9
26
n
26
HS9
26
B
1.3326
0.3700
0.0803
0.7513
0.3560
2.2624
0.1523
-0.1018
-0.0128
0.0046
-0.1075
-0.0014
-0.1193
0.0686
-0.0448
0.0252
-0.0129
0.0017
0.0250
0.0030
0.0249
refined
-10.4859
7.2819
-7.1897
X-RAY DIFFRACTION
A
1
A
21
X-RAY DIFFRACTION
1
B
2
B
26
X-RAY DIFFRACTION
1
author_and_software_defined_assembly
PISA
4
tetrameric
3790
-32.1
5800
B
HS9
26
N-ALPHA-METHYL-L-HISTIDINAMIDE
B
HS9
26
HIS
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
5_454
-x-1/2,y,-z-1/4
crystal symmetry operation
-19.5850000000
0.0000000000
-30.8982500000
1
B
PHE
1
B
PHE
1
1
Y
16.638
0.10
0.00
0.00
0.10
0.00
-0.20
0.940
0.911
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES RESIDUAL
0.277
0.19951
0.20298
2.15
37.34
126
2686
4.5
97.60
13.073
0.147
RANDOM
LIKELY RESIDUAL
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.277
0.239
0.80
0.80
1.40
PDB ENTRY 1MSO
MAXIMUM LIKELIHOOD
MASK
2.15
37.34
45
412
4
0
363
0.021
0.021
374
1.677
1.946
506
7.273
5.000
44
42.253
24.737
19
16.425
15.000
58
5.317
15.000
1
0.135
0.200
55
0.008
0.020
289
1.020
1.500
229
1.835
2.000
362
2.812
3.000
145
4.422
4.500
144
0.394
0.219
2.208
8
195
20
97.60
24.7
2.15
37.34
2WRV
4113
0.0
0.07
1
14.50
7.2
97.8
0.269
2.15
2.19
6.80
1
7.0
97.4
refinement
REFMAC
5.5.0082
data reduction
DENZO
data scaling
SCALEPACK
phasing
MOLREP
Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2
1
N
N
2
N
N
3
N
N
4
N
N
4
N
N
A
ILE
2
A
ILE
2
HELX_P
A
CYS
7
A
CYS
7
1
1
6
A
SER
12
A
SER
12
HELX_P
A
ASN
18
A
ASN
18
1
2
7
B
SER
9
B
SER
9
HELX_P
B
CYS
19
B
CYS
19
1
3
11
disulf
2.038
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.041
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
1.997
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
covale
1.338
one
B
PHE
25
B
C
PHE
25
1_555
B
HS9
26
B
N
HS9
26
1_555
HORMONE
CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, DIABETES MELLITUS
B
PHE
25
B
PHE
25
1
B
HS9
26
B
HS9
26
2.36
INS_HUMAN
UNP
1
P01308
INS_HUMAN
UNP
2
P01308
90
110
2WRV
1
21
P01308
A
1
1
21
25
50
2WRV
1
26
P01308
B
2
1
26
2
TYR
engineered mutation
HS9
26
2WRV
B
P01308
UNP
50
26
BINDING SITE FOR RESIDUE ACT A 1022
A
ACT
1022
Software
1
B
HIS
10
B
HIS
10
1
10_465
98
I 41 2 2